NEW YORK, May 1 (Reuters) - Purdue Pharma said on Friday that it has ceased operations and concluded its bankruptcy, re-emerging as a nonprofit focused on treating ‌opioid addiction, overseen by a new ...

Purdue Pharma, the bankrupted drug manufacturer at the center of the nation’s yearslong opioid epidemic, shut down May 1. The ...

NEW YORK, April 28 (Reuters) - Purdue Pharma will be sentenced on Tuesday in New Jersey federal court for deceiving government regulators and paying kickbacks to doctors to boost opioid sales, ...

Newark, New Jersey - A federal judge on Tuesday criminally sentenced OxyContin-maker Purdue Pharma over its role in the opioid crisis, ahead of upcoming bankruptcy proceedings and its dissolution.

NEW YORK - Consulting firm McKinsey & Co has agreed to contribute $125 million to Purdue Pharma’s bankruptcy settlement, resolving potential legal claims over advice it provided to Purdue on how to ...

News broke Monday that Purdue Pharma, the pharmaceutical giant behind the addictive prescription opioid OxyContin, is considering filing for bankruptcy. Such a move could let Purdue off the hook for ...

Purdue Pharma pleaded guilty Tuesday to three criminal charges, formally taking responsibility for its part in an opioid epidemic that has contributed to hundreds of thousands of deaths but also ...